Sword Pharmaceuticals Private Limited
About Sword Pharmaceuticals Private Limited
Data last updated:
Sword Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2012PTC227994. Its GSTIN is 27AARCS2078L1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Atul Bhagwanji Urkude and Nisha Atul Urkude.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 6 Om Sai Om Karbi Road Shesh Nagar, Nagpur, Maharashtra, India – 440009.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.96 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹1.51 Lakh (net margin -2.1%) and EBITDA of ₹6.7 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹6 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 6 Om Sai Om Karbi Road Shesh Nagar, Nagpur, Maharashtra, India – 440009
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sword Pharmaceuticals Private Limited
The main business activity of Sword Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sword Pharmaceuticals Private Limited FY 2025 filings available
Sword Pharmaceuticals Private Limited reported revenue of ₹70.96 Lakh (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sword Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 18% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sword Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.51 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sword Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sword Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| San Smith Pharma Private Limited | ₹71.18 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Kurukshetra, Haryana, India |
| NMR Healthcare Private Limited | ₹71.16 Lakh (FY 2025) | •••• | •••• | •••• | Ludhiana, Punjab, India | |
| Sukhashree Healthcare Private Limited | ₹71.15 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Buldana, Maharashtra, India |
| Rtu Organic Private Limited | ₹71.09 Lakh (FY 2025) | •••• | •••• | 51.0% | •••• | Patna, Bihar, India |
| Sahyog Hospital Private Limited | ₹71.05 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Rajkot, Gujarat, India |
| Sword Pharmaceuticals Private Limited this company | ₹70.96 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Nagpur, Maharashtra, India |
| RBL Pharma Chem Private Limited | ₹70.92 Lakh (FY 2022) | •••• | •••• | •••• | Delhi, India | |
| Vizag Pharmaceuticals Private Limited | ₹70.81 Lakh (FY 2016) | •••• | •••• | -52.0% | •••• | Hyderabad, Telangana, India |
| Ecstatic Pharmaceuticals Private Limited | ₹70.76 Lakh (FY 2023) | •••• | •••• | 13.0% | •••• | Thane, Maharashtra, India |
| Physa Pharmaceuticals Private Limited | ₹70.69 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Noida, Uttar Pradesh, India |
| Medimyelin Pharmaceuticals Private Limited | ₹70.63 Lakh (FY 2024) | •••• | •••• | 695.0% | •••• | Guwahati, Assam, India |
Peers are the five companies nearest above and the five nearest below Sword Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals Private Limited is audited by R D SAWALKAR & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R D SAWALKAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Bhagwanji Urkude | Director | 13 Mar 2012 | 14 Years 6 Months | Current |
| Nisha Atul Urkude | Director | 19 Jun 2025 | 1 Years 3 Months | Current |
Ownership and Shareholding of Sword Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sword Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2020 | Others | ₹6 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Sword Pharmaceuticals, 1 where it is another party. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Court case (CS CJ) | Company is another party | Disposed |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against an individual | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Sword Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Sword Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Bhagwan Dhonduji Urkude ceased to be Director on 20 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts for Sword Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sword Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sword Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCS2078L1ZM | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sword Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sword Pharmaceuticals Private Limited
Sword Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 March 2012 (14+ years old) and is registered under CIN U24232MH2012PTC227994.
Sword Pharmaceuticals reported revenue of ₹70.96 Lakh for FY 2025 (up 18% YoY).
Sword Pharmaceuticals has 2 current directors:
- Atul Bhagwanji Urkude - Director
- Nisha Atul Urkude - Director
Sword Pharmaceuticals reported a net loss of ₹1.51 Lakh (net margin -2.1%) and EBITDA of ₹6.7 Lakh (EBITDA margin 9.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sword Pharmaceuticals is 7% over three years and 2% over five years. In the latest year (FY 2025) revenue rose 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sword Pharmaceuticals is 27AARCS2078L1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sword Pharmaceuticals is U24232MH2012PTC227994. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sword Pharmaceuticals has 2 court cases on record: 1 filed by the company.
Sword Pharmaceuticals was incorporated on 13 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sword Pharmaceuticals by revenue are San Smith Pharma Private Limited, NMR Healthcare Private Limited, Sukhashree Healthcare Private Limited, Rtu Organic Private Limited, Sahyog Hospital Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Bhagwan Dhonduji Urkude ceased to be Director on 20 Jun 2025. Nisha Atul Urkude was appointed as Director on 19 Jun 2025. Bhagwan Dhonduji Urkude was appointed as Director on 21 Apr 2017. Sword Pharmaceuticals has 6 board changes on record in total.